|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - RHYTHM PHARMACEUTICALS Inc (RYTM)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-03-15 Sale |
2019-03-19 4:25 pm |
RHYTHM PHARMACEUTICALS Inc | RYTM | Gottesdiener Keith Michael CEO |
10,290 | $30.09 | $309,647 | 508,671 (Direct) |
View |
| 2019-03-13 Sale |
2019-03-15 4:01 pm |
RHYTHM PHARMACEUTICALS Inc | RYTM | Gottesdiener Keith Michael CEO |
9,288 | $30.06 | $279,182 | 518,138 (Direct) |
View |
| 2019-02-26 Sale |
2019-02-28 4:01 pm |
RHYTHM PHARMACEUTICALS Inc | RYTM | Gottesdiener Keith Michael CEO |
2,449 | $30.04 | $73,571 | 527,431 (Direct) |
View |
| 2019-02-15 Sale |
2019-02-20 4:01 pm |
RHYTHM PHARMACEUTICALS Inc | RYTM | Gottesdiener Keith Michael CEO |
12,920 | $30.02 | $387,886 | 528,984 (Direct) |
View |
| 2019-02-13 Sale |
2019-02-15 4:09 pm |
RHYTHM PHARMACEUTICALS Inc | RYTM | Gottesdiener Keith Michael CEO |
3,934 | $30 | $118,020 | 540,986 (Direct) |
View |
| 2019-01-22 Sale |
2019-01-24 4:03 pm |
RHYTHM PHARMACEUTICALS Inc | RYTM | Gottesdiener Keith Michael CEO |
15,779 | $30.05 | $474,176 | 545,025 (Direct) |
View |
| 2019-01-18 Sale |
2019-01-22 4:07 pm |
RHYTHM PHARMACEUTICALS Inc | RYTM | Gottesdiener Keith Michael CEO |
10,115 | $30.01 | $303,551 | 560,699 (Direct) |
View |
| 2019-01-16 Sale |
2019-01-18 4:02 pm |
RHYTHM PHARMACEUTICALS Inc | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer |
200 | $30 | $6,000 | 42,339 (Direct) |
View |
| 2019-01-16 Sale |
2019-01-17 6:13 pm |
RHYTHM PHARMACEUTICALS Inc | RYTM | Gottesdiener Keith Michael CEO |
662 | $30 | $19,860 | 570,814 (Direct) |
View |
| 2018-12-03 Sale |
2018-12-06 4:03 pm |
RHYTHM PHARMACEUTICALS Inc | RYTM | Gottesdiener Keith Michael CEO |
563 | $30 | $16,890 | 571,476 (Direct) |
View |
| 2018-11-02 Sale |
2018-11-06 5:21 pm |
RHYTHM PHARMACEUTICALS Inc | RYTM | Gottesdiener Keith Michael CEO |
16,500 | $30.08 | $496,320 | 572,039 (Direct) |
View |
| 2018-11-02 Sale |
2018-11-06 5:20 pm |
RHYTHM PHARMACEUTICALS Inc | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer |
38,000 | $30.09 | $1,143,420 | 80,539 (Direct) |
View |
| 2018-09-25 Sale |
2018-09-27 4:02 pm |
RHYTHM PHARMACEUTICALS Inc | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer |
31,800 | $29.8 | $947,540 | 84,139 (Direct) |
View |
| 2018-05-22 Sale |
2018-05-24 4:13 pm |
RHYTHM PHARMACEUTICALS Inc | RYTM | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC 10% Owner |
19,580 | $30.43 | $595,768 | 2,751,679 (Indirect) |
View |
| 2018-05-18 Sale |
2018-05-21 6:15 pm |
RHYTHM PHARMACEUTICALS Inc | RYTM | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC 10% Owner |
131,636 | $30.88 | $4,065,440 | 2,832,159 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-02-13 Option Award |
2019-02-15 4:10 pm |
N/A 2029-02-12 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Smith Hunter C CFO |
70,000 | $29.78 | 70,000 (Direct) |
View |
| 2019-02-13 Option Award |
2019-02-15 4:09 pm |
N/A 2029-02-12 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Gottesdiener Keith Michael CEO |
225,000 | $29.78 | 540,986 (Direct) |
View |
| 2019-02-13 Option Award |
2019-02-15 4:09 pm |
N/A 2029-02-12 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Desikan Nithya Chief Commercial Officer |
70,000 | $29.78 | 70,000 (Direct) |
View |
| 2019-02-13 Option Award |
2019-02-15 4:08 pm |
N/A 2029-02-12 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Stewart Murray Chief Medical Officer |
60,000 | $29.78 | 60,000 (Direct) |
View |
| 2019-02-13 Option Award |
2019-02-15 4:08 pm |
N/A 2029-02-12 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer |
70,000 | $29.78 | 70,000 (Direct) |
View |
| 2019-02-13 Option Award |
2019-02-15 4:07 pm |
N/A 2029-02-12 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Kelner Simon Chief Human Resources Officer |
55,000 | $29.78 | 55,000 (Direct) |
View |
| 2019-01-31 Exercise |
2019-02-04 4:01 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Smith Hunter C CFO |
3,000 | $6.88 | 195,744 (Direct) |
View |
| 2019-01-31 Exercise |
2019-02-04 4:01 pm |
N/A 2027-08-08 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Smith Hunter C CFO |
3,000 | $6.88 | 195,744 (Direct) |
View |
| 2018-11-02 Exercise |
2018-11-06 5:20 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer |
8,200 | $4.59 | 80,539 (Direct) |
View |
| 2018-11-02 Exercise |
2018-11-06 5:20 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer |
10,000 | $6.14 | 80,539 (Direct) |
View |
| 2018-11-02 Exercise |
2018-11-06 5:20 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer |
10,000 | $7.52 | 80,539 (Direct) |
View |
| 2018-11-02 Exercise |
2018-11-06 5:20 pm |
N/A 2025-11-16 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer |
8,200 | $4.59 | 80,539 (Direct) |
View |
| 2018-11-02 Exercise |
2018-11-06 5:20 pm |
N/A 2027-04-04 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer |
10,000 | $6.14 | 80,539 (Direct) |
View |
| 2018-11-02 Exercise |
2018-11-06 5:20 pm |
N/A 2025-12-30 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer |
10,000 | $7.52 | 80,539 (Direct) |
View |
| 2018-10-15 Option Award |
2018-10-17 5:30 pm |
N/A 2028-10-14 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Stewart Murray Chief Medical Officer |
100,000 | $26.54 | 100,000 (Direct) |
View |
| 2018-09-25 Gift |
2018-09-27 4:02 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer |
2,000 | $0 | 84,139 (Direct) |
View |
| 2018-09-25 Exercise |
2018-09-27 4:02 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer |
21,800 | $4.59 | 84,139 (Direct) |
View |
| 2018-09-25 Exercise |
2018-09-27 4:02 pm |
N/A 2025-11-16 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer |
21,800 | $4.59 | 84,139 (Direct) |
View |
| 2018-09-05 Exercise |
2018-09-06 4:02 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Smith Hunter C CFO |
3,000 | $6.88 | 198,744 (Direct) |
View |
| 2018-09-05 Exercise |
2018-09-06 4:02 pm |
N/A 2027-08-08 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Smith Hunter C CFO |
3,000 | $6.88 | 198,744 (Direct) |
View |
| 2018-08-30 Other |
2018-09-04 4:06 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | THIRD ROCK VENTURES LP Third Rock Ventures GP L.P. TRV GP LLC STARR KEVIN P TEPPER ROBERT I LEVIN MARK J 10% Owner |
1,000,000 | $0 | 2,981,437 (Direct) |
View |
| 2018-08-10 Exercise |
2018-08-14 4:01 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Desikan Nithya Chief Commercial Officer |
14,534 | $6.88 | 187,210 (Direct) |
View |
| 2018-08-10 Exercise |
2018-08-14 4:01 pm |
N/A 2027-08-08 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Desikan Nithya Chief Commercial Officer |
14,534 | $6.88 | 187,210 (Direct) |
View |
| 2018-06-06 Option Award |
2018-06-08 5:04 pm |
N/A 2028-06-05 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Mathers Edward T Director |
10,000 | $34.89 | 10,000 (Direct) |
View |
| 2018-06-06 Option Award |
2018-06-08 4:09 pm |
N/A 2028-06-05 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Kelner Simon Chief Human Resources Officer |
60,000 | $34.89 | 60,000 (Direct) |
View |
| 2018-06-06 Option Award |
2018-06-08 4:08 pm |
N/A 2028-06-05 |
RHYTHM PHARMACEUTICALS Inc | RYTM | JEAN CHRISTOPHE Director |
10,000 | $34.89 | 10,000 (Direct) |
View |
| 2018-06-06 Option Award |
2018-06-08 4:06 pm |
N/A 2028-06-05 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Exter Neil Director |
10,000 | $34.89 | 10,000 (Direct) |
View |
| 2018-06-06 Option Award |
2018-06-08 4:06 pm |
N/A 2028-06-05 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Meeker David P Director |
10,000 | $34.89 | 10,000 (Direct) |
View |
| 2018-06-06 Option Award |
2018-06-08 4:04 pm |
N/A 2028-06-05 |
RHYTHM PHARMACEUTICALS Inc | RYTM | MCGIRR DAVID W J Director |
10,000 | $34.89 | 10,000 (Direct) |
View |
| 2018-06-06 Option Award |
2018-06-08 4:03 pm |
N/A 2028-06-05 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Foley Todd Director |
10,000 | $34.89 | 10,000 (Direct) |
View |
| 2018-05-09 Exercise |
2018-05-10 4:08 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Gottesdiener Keith Michael CEO |
3,000 | $4.59 | 588,539 (Direct) |
View |
| 2018-05-09 Exercise |
2018-05-10 4:08 pm |
N/A 2025-11-16 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Gottesdiener Keith Michael CEO |
3,000 | $4.59 | 588,539 (Direct) |
View |
| 2018-02-14 Option Award |
2018-02-16 4:03 pm |
N/A 2028-02-13 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Smith Hunter C CFO |
61,000 | $25.79 | 61,000 (Direct) |
View |
| 2018-02-14 Option Award |
2018-02-16 4:03 pm |
N/A 2028-02-13 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Gottesdiener Keith Michael CEO |
175,000 | $25.79 | 175,000 (Direct) |
View |
| 2018-02-14 Option Award |
2018-02-16 4:03 pm |
N/A 2028-02-13 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Fiedorek Fred T. Chief Medical Officer |
25,000 | $25.79 | 25,000 (Direct) |
View |
| 2018-02-14 Option Award |
2018-02-16 4:03 pm |
N/A 2028-02-13 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Fiedorek Fred T. Chief Medical Officer |
25,000 | $25.79 | 25,000 (Direct) |
View |
| 2018-02-14 Option Award |
2018-02-16 4:02 pm |
N/A 2028-02-13 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Desikan Nithya Chief Commercial Officer |
61,000 | $25.79 | 61,000 (Direct) |
View |
| 2018-02-14 Option Award |
2018-02-16 4:02 pm |
N/A 2028-02-13 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer |
55,000 | $25.79 | 55,000 (Direct) |
View |
| 2017-10-10 Conversion |
2017-10-12 5:16 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Exter Neil Director |
0 | $0 | 0 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-12 5:16 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Exter Neil Director |
0 | $0 | 0 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-12 5:16 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Exter Neil Director |
0 | $0 | 0 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-11 4:00 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | THIRD ROCK VENTURES LP Third Rock Ventures GP L.P. TRV GP LLC LEVIN MARK J STARR KEVIN P TEPPER ROBERT I 10% Owner |
3,963,810 | $0 | 3,981,437 (Direct) |
View |
| 2017-10-10 Conversion |
2017-10-11 4:00 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | THIRD ROCK VENTURES LP Third Rock Ventures GP L.P. TRV GP LLC LEVIN MARK J STARR KEVIN P TEPPER ROBERT I 10% Owner |
9,479,502 | $0 | 3,981,437 (Direct) |
View |
| 2017-10-10 Conversion |
2017-10-11 4:00 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | THIRD ROCK VENTURES LP Third Rock Ventures GP L.P. TRV GP LLC LEVIN MARK J STARR KEVIN P TEPPER ROBERT I 10% Owner |
26,868,642 | $0 | 3,981,437 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Thu, 23 May 2019 22:21:45 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |